News & Updates

Show Multimedia Only
Hypertension in pregnancy: Labetalol extends benefits for pregnancy outcomes

Hypertension in pregnancy: Labetalol extends benefits for pregnancy outcomes

22 Feb 2022 byJairia Dela Cruz

Common blood pressure (BP)-lowering medications in pregnancy cut the risk of severe hypertension, but labetalol has the added advantage of reducing the risks of proteinuria or pre-eclampsia and perinatal death, according to the results of a network meta-analysis.

22 Feb 2022
NOACs preferable over warfarin in AF patients with bioprosthetic valves NOACs preferable over warfarin in AF patients with bioprosthetic valves

NOACs preferable over warfarin in AF patients with bioprosthetic valves

22 Feb 2022 byStephen Padilla

Use of nonvitamin K oral anticoagulants (NOACs) results in a reduced incidence of thromboembolic events and major bleeding relative to warfarin in patients with atrial fibrillation (AF) and bioprosthetic valves or valve repair, suggests a study.

22 Feb 2022
Lipoprotein(a) molar concentrations help inform cardiovascular risk

Lipoprotein(a) molar concentrations help inform cardiovascular risk

19 Feb 2022

The risk of coronary artery disease (CAD) can be predicted by a single accurate measurement of lipoprotein(a) molar concentration if therapies substantially altering lipoprotein(a) are not present, suggests a recent study.

19 Feb 2022
Edoxaban effectively keeps D-dimer low in patients with NVAF, AHF

Edoxaban effectively keeps D-dimer low in patients with NVAF, AHF

19 Feb 2022

Patients with nonvalvular atrial fibrillation (NVAF) and acute heart failure (AHF) see elevated levels of D-dimer, for which edoxaban may be effective, reports a recent study.

19 Feb 2022